These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12131334)

  • 1. Can oxybutynin cause peripheral neuropathy?
    Patel HR; Albehussi S; Arya M; Miller RA
    J Urol; 2002 Aug; 168(2):646. PubMed ID: 12131334
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of unstable bladder with oxybutynin hydrochloride. Our clinical experience in 80 cases].
    Alladio F; Arena G; Ferrando U; Pigato M; Sesia G
    Minerva Urol Nefrol; 1987; 39(4):359-62. PubMed ID: 3451374
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of oxybutynin chloride on bladder spasm following transurethral surgery.
    Wein AJ; Hanno PM; Raezer DM; Benson GS
    Urology; 1978 Aug; 12(2):184-6. PubMed ID: 358527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe anticholinergic drug-induced delirium in a young adult after renal transplantation.
    Götz AK; Reinhold SW; Szecsey A; Banas B; Krämer BK
    Transpl Int; 2009 Feb; 22(2):249-50. PubMed ID: 18786150
    [No Abstract]   [Full Text] [Related]  

  • 5. [Instability of the detrusor muscle. Treatment with oxybutynin chloride (ditropan)].
    Perales Cabanas L; Tallada Buñuel M; Romero Maroto J; Escribano Patiño G
    Actas Urol Esp; 1986; 10(6):481-6. PubMed ID: 3825651
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravesical baclofen, bupivacaine, and oxycodone for the relief of bladder spasm.
    Wallace E; Twomey M; Victory R; O'Reilly M
    J Palliat Care; 2013; 29(1):49-51. PubMed ID: 23614171
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxybutynin: is it safe?
    Baigrie RJ; Kelleher JP; Fawcett DP; Pengelly AW
    Br J Urol; 1988 Oct; 62(4):319-22. PubMed ID: 3191355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
    Schaefer W
    Int J Urol; 2007 Jul; 14(7):670; author reply 670-1. PubMed ID: 17645621
    [No Abstract]   [Full Text] [Related]  

  • 9. [Oxybutynin chloride in pediatrics: extenuating circumstances].
    Aubert D
    Arch Fr Pediatr; 1988 May; 45(5):375-6. PubMed ID: 3415420
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and treatment of urinary bladder dysfunctions in patients with nephrotuberculosis].
    Zuban' ON; Iagafarova RK; Vinogradova TI
    Urologiia; 2006; (5):37-40, 45. PubMed ID: 17444151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of overactive bladder with modified intravesical oxybutynin chloride.
    Saito M; Tabuchi F; Otsubo K; Miyagawa I
    Neurourol Urodyn; 2000; 19(6):683-8. PubMed ID: 11071699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Topical use of oxybutynin hydrochloride in women with urge incontinence].
    Enzelsberger H; Kurz C; Helmer H
    Gynakol Geburtshilfliche Rundsch; 1994; 34(1):23-4. PubMed ID: 8019165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strangury: the case of a symptom with ancient origins.
    Wright B; Husbands E
    BMJ Support Palliat Care; 2011 Jun; 1(1):49-50. PubMed ID: 24653049
    [No Abstract]   [Full Text] [Related]  

  • 17. The use of oxybutynin in urological practice.
    Kirkali Z; Whitaker RH
    Int Urol Nephrol; 1987; 19(4):385-91. PubMed ID: 3429165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal oxybutynin. A viewpoint by Adrian Wagg.
    Wagg A
    Drugs Aging; 2003; 20(11):865-6. PubMed ID: 12964894
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxybutynin transdermal (Oxytrol) for overactive bladder.
    Med Lett Drugs Ther; 2003 May; 45(1156):38-9. PubMed ID: 12736598
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose oxybutynin for the unstable bladder.
    Malone-Lee J; Lubel D; Szonyi G
    BMJ; 1992 Apr; 304(6833):1053. PubMed ID: 1586797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.